Variant report
Variant | esv3453503 |
---|---|
Chromosome Location | chr1:228818828-228820117 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | GATA3 | chr1:228818604-228819150 | MCF-7 | breast: | n/a | chr1:228818624-228818631 chr1:228818980-228818997 chr1:228818624-228818631 chr1:228818624-228818631 chr1:228818983-228818990 |
2 | MAFF | chr1:228819299-228819499 | HepG2 | liver: | n/a | n/a |
3 | MAFF | chr1:228819283-228819483 | K562 | blood: | n/a | n/a |
4 | MAFK | chr1:228819221-228819536 | HepG2 | liver: | n/a | chr1:228819363-228819378 |
5 | MAFK | chr1:228819311-228819389 | HepG2 | liver: | n/a | chr1:228819363-228819378 |
6 | MAFK | chr1:228819251-228819481 | IMR90 | lung: | n/a | chr1:228819363-228819378 |
7 | SIN3AK20 | chr1:228818679-228819213 | MCF-7 | breast: | n/a | n/a |
No data |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
FTH1P2 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs34813976 | chr1:228818919-228818920 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs10916354 | chr1:228818957-228818958 | Weak transcription Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
3 | rs527483566 | chr1:228818962-228818963 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs547298621 | chr1:228819060-228819061 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs567175449 | chr1:228819118-228819119 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs536266970 | chr1:228819119-228819120 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs374959495 | chr1:228819147-228819148 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs74942298 | chr1:228819148-228819149 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs16848856 | chr1:228819166-228819167 | Weak transcription | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs142523548 | chr1:228819169-228819170 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs150926357 | chr1:228819170-228819171 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs28593575 | chr1:228819227-228819228 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs373754275 | chr1:228819242-228819243 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs570073898 | chr1:228819257-228819258 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs139652372 | chr1:228819259-228819260 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs183663227 | chr1:228819264-228819265 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs575153800 | chr1:228819331-228819332 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs115708117 | chr1:228819385-228819386 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs556220925 | chr1:228819404-228819405 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs575943234 | chr1:228819492-228819493 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs115494082 | chr1:228819498-228819499 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs78665587 | chr1:228819514-228819515 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs552207913 | chr1:228819535-228819536 | Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs527484708 | chr1:228819541-228819542 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs540797596 | chr1:228819557-228819558 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs371357427 | chr1:228819571-228819572 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs149743077 | chr1:228819574-228819575 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs373515589 | chr1:228819592-228819593 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs146740491 | chr1:228819629-228819630 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs570072784 | chr1:228819669-228819670 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs115029184 | chr1:228819676-228819677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs376268522 | chr1:228819752-228819753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs140343415 | chr1:228819785-228819786 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs145407288 | chr1:228819789-228819790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs189053014 | chr1:228819807-228819808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs370344795 | chr1:228819808-228819809 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs565930632 | chr1:228819809-228819810 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs367980339 | chr1:228819824-228819825 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs555238630 | chr1:228819853-228819854 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs180795757 | chr1:228819854-228819855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs554370029 | chr1:228819927-228819928 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs537786902 | chr1:228819945-228819946 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs557358385 | chr1:228819964-228819965 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs185686854 | chr1:228819969-228819970 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs575994805 | chr1:228819970-228819971 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs544631427 | chr1:228819973-228819974 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs558641427 | chr1:228819975-228819976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs572009506 | chr1:228819980-228819981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs540708947 | chr1:228819981-228819982 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs560797177 | chr1:228819984-228819985 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Autism | 14699429 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Congenital abnormalities | 21549014 | CNVD |
Developmental delay | 21549014 | CNVD |
Mental retardation | 21549014 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 17060936 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:228817400-228820000 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
2 | chr1:228817800-228819000 | Enhancers | Duodenum Mucosa | Duodenum |
3 | chr1:228820000-228820400 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
4 | chr1:228820000-228821000 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr1:228820000-228821200 | Enhancers | Placenta | Placenta |